Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot trial is to study efficacy and safety of simultaneous intravenous
(iv) ibuprofen/indomethacin and paracetamol medications in the closure of patent ductus
arteriosus (PDA) in preterm infants. It is randomized, placebo-controlled, double-blind,
phase 1, multicenter, clinical trial.
Phase:
Phase 1
Details
Lead Sponsor:
University of Oulu
Collaborators:
Helsinki University Central Hospital Tartu University Hospital Turku University Hospital